| Passarin MG, Moretto G, Musso AM, et al.
Intrathecal liposomal cytarabine in combination with temozolomide in low-grade oligoastrocytoma with leptomeningeal dissemination. [JOURNAL ARTICLE]
J Neurooncol 2009 Oct 31.
Abstract | Full Citation | | Radujkovic A, Fruehauf S, Zeller WJ, et al.
Synergistic activity of nilotinib and established chemotherapeutic drugs in imatinib-sensitive and -resistant BCR-ABL-positive cells. [JOURNAL ARTICLE]
Cancer Chemother Pharmacol 2009 Oct 28.
Abstract | Full Citation | | McHayleh W, Sehgal R, Redner RL, et al.
Mitoxantrone and etoposide in patients with newly diagnosed acute myeloid leukemia with persistent leukemia after a course of therapy with cytarabine and idarubicin. [JOURNAL ARTICLE]
Leuk Lymphoma 2009 Oct 8.
Abstract | Full Citation | | Jin Y, Liu S, Yu B, et al.
Targeted Delivery of Antisense Oligodeoxynucleotide by Transferrin Conjugated pH-Sensitive Lipopolyplex Nanoparticles: A Novel Oligonucleotide -Based Therapeutic Strategy in Acute Myeloid Leukemia. [JOURNAL ARTICLE]
Mol Pharm 2009 Oct 23.
Abstract | Full Citation | | Prenkert M, Uggla B, Tina E, et al.
Rapid Induction of P-Glycoprotein mRNA and Protein Expression by Cytarabine in HL-60 Cells. [Journal Article]
Anticancer Res 2009 Oct; 29(10):4071-6.
Abstract | Full Citation | | Papayannidis C, Derenzini E, Iacobucci I, et al.
Successful combination treatment of clofarabine, cytarabine, and gemtuzumab-ozogamicin in adult refractory B-acute lymphoblastic leukemia. [JOURNAL ARTICLE]
Am J Hematol 2009 Sep 16.
Full Citation | | Nicolini FE, Mauro MJ, Martinelli G, et al.
Epidemiological study on survival of chronic myeloid leukemia (CML) and Ph+ acute lymphoblastic leukemia (ALL) patients with BCR-ABL T315I mutation. [JOURNAL ARTICLE]
Blood 2009 Oct 20.
Abstract | Full Citation | Publisher Full Text | Find Related Articles | | Perl AE, Kasner MT, Tsai DE, et al.
A Phase I Study of the Mammalian Target of Rapamycin Inhibitor Sirolimus and MEC Chemotherapy in Relapsed and Refractory Acute Myelogenous Leukemia. [JOURNAL ARTICLE]
Clin Cancer Res 2009 Oct 20.
Abstract | Full Citation | | Lamba JK
Genetic factors influencing cytarabine therapy. [Journal Article]
Pharmacogenomics 2009 Oct; 10(10):1657-74.
Abstract | Full Citation | | Mandelli F, Vignetti M, Suciu S, et al.
Daunorubicin versus mitoxantrone versus idarubicin as induction and consolidation chemotherapy for adults with acute myeloid leukemia: the EORTC and GIMEMA Groups Study AML-10. [Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't]
J Clin Oncol 2009 Nov 10; 27(32):5397-403.
Abstract | Full Citation | Find Related Articles |    |
|
| |
Advertise on this site.
|
